ApicHope Pharmaceutical Group Co., Ltd. (300723.SZ) — Stock Score Summary

ApicHope Pharmaceutical Group Co., Ltd. (300723.SZ) has a MoatMap StockRank of 30/100 based on Quality (46/100), Value (35/100), and Momentum (37/100) factor scores. The current signal is SELL. ApicHope is a domestic Chinese pharmaceutical company focused on pediatric and generic drugs. It lacks the global scale, regulatory moats, and high-utilization CDMO characteristics required to benefit from our CDMO pricing power theme.

ApicHope Pharmaceutical Group Co., Ltd. develops, manufactures, and markets specialty pharmaceuticals, with a core focus on pediatric medicines, generic drugs, and active pharmaceutical ingredients (APIs). The company is a market leader in China's pediatric healthcare segment, leveraging a comprehensive portfolio of child-friendly formulations. It is characterized by its robust R&D pipeline and strong brand recognition among domestic hospitals and pharmacies.

Key Financial Metrics

Price$5.05
Market Cap$2.9B
P/E (TTM)85.77
P/E (Forward)57.18
Price/Book8.74
Return on Equity9.7%
Return on Invested Capital-10.7%
Debt/Equity105.73
Gross Margin57.4%
Operating Margin6.1%
Revenue Growth2.3%
Free Cash Flow$9M

ApicHope Pharmaceutical Group Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is ApicHope Pharmaceutical Group Co., Ltd.’s (300723.SZ) StockRank?
MoatMap’s StockRank for ApicHope Pharmaceutical Group Co., Ltd. (300723.SZ) is 30/100, with a Sell signal. It is a composite of Quality (46), Value (35), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does ApicHope Pharmaceutical Group Co., Ltd. have an economic moat?
ApicHope Pharmaceutical Group Co., Ltd. (300723.SZ) has a Quality factor score of 46/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ApicHope Pharmaceutical Group Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for ApicHope Pharmaceutical Group Co., Ltd. (300723.SZ) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ApicHope Pharmaceutical Group Co., Ltd. in?
ApicHope Pharmaceutical Group Co., Ltd. (300723.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).